510(k) device
Prontosan Wound Gel
B.Braun Medical, Inc. · Dressing, Wound, Drug (FRO, Unclassified) · First FDA decision Jun 19, 2008, newest May 23, 2017Chronic wounds and ulcers
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
510(k) pathway
Device trials
16
Naming "Prontosan"
MAUDE reports
56
Brand "Prontosan", since 2015
PubMed studies
64
Mentioning "Prontosan"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Prontosan Wound Gel
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 5 of 5 decisions filed under this name.
- Prontosan Wound Gel510(k)
K163430 · Decided May 23, 2017 · 167 days after receipt
Device type: Dressing, Wound, Drug (FRO) · General & Plastic Surgery
K161623 · Decided Nov 10, 2016 · 150 days after receipt
Device type: Dressing, Wound, Drug (FRO) · General & Plastic Surgery
- PRONTOSAN WOUND GEL X510(k)
K130857 · Decided Oct 8, 2013 · 194 days after receipt
Device type: Dressing, Wound, Drug (FRO) · General & Plastic Surgery
2 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Prontosan", any status and sponsor, newest update first.
IRCCS Policlinico S. DonatoAcademic, hospital or other
NCT07275307 · 456 participants (planned) · Start Feb 2, 2026 · Primary completion Jul 2027
Device: Application of Prontosan Wound Gel X · For: Surgical Site Infection After Major Surgery
Sites: San Donato Milanese, Italy
St. Louis UniversityAcademic, hospital or other
NCT07406893 · 60 participants (planned) · Start Feb 23, 2026 · Primary completion Dec 2026
Device: Prontosan Wound Gel · For: Joint Arthroplasty; Shoulder; Cutibacterium Acnes and 1 more
Sites: St Louis, Missouri
- SALACIA: SALvesAn vs Conventional Management of dIAbetic Foot WoundsPivotal-lookingNot yet recruiting
NHS LanarkshireGovernment (non-federal)
NCT06908148 · 200 participants (planned) · Start Jul 1, 2025 · Primary completion Jul 1, 2026
Device: Electrolysed water; Conventional irrigant · For: Foot Ulcers, Diabetic; Foot Ulcer Unhealed
13 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Prontosan", and for the whole product code for context.
This brand
56 reports: 0 malfunction, 55 injury, 0 death
Whole product code FRO
2,371 reports: 1,097 malfunction, 1,190 injury, 48 death
Newest reports for this brand
- ProntosanInjury
3007120504-2026-00003 · Received Sep 10, 2026 · Event dated Aug 7, 2026
Device type: Dressing, Wound, Drug (FRO)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Bradycardia; Diarrhea; Low Blood Pressure/ Hypotension; Anaphylactoid / Anaphylaxis
- ProntosanInjury
3007120504-2026-00002 · Received Aug 11, 2026 · Event dated Jul 21, 2026
Device type: Dressing, Wound, Drug (FRO)
Device problem as coded: Improper or Incorrect Procedure or Method
Patient problem as coded: Hot Flashes/Flushes; Dizziness; Loss of consciousness
- PRONTOSANInjury
3007120504-2026-00001 · Received May 8, 2026 · Event dated Feb 24, 2026
Device type: Dressing, Wound, Drug (FRO)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Anaphylactic Shock; Low Blood Pressure/ Hypotension
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Prontosan"[tiab]. The summary above synthesizes these.
- A retrospective systematic data review on the use of a polihexanide-containing product on burns in children.
Ciprandi G, Ramsay S, Budkevich L, et al. · J Tissue Viability · 2018
- Quality of life case series review: wound bed preparation from a UK perspective.
Bhatt P · Br J Community Nurs · 2024Review
- The efficacy of antimicrobial solutions against multispecies bacterial biofilm with or without negative pressure wound therapy in an in vitro wound model.
Tahir S, Parvin F, Wang M, et al. · J Antimicrob Chemother · 2024Research Support, Non-U.S. Gov't
- [Primary wound care in children].
Scherer C, Berger S · Ther Umsch · 2020
- Infected Diabetic Wound Regeneration Using Peptide-Modified Chiral Dressing to Target Revascularization.
Xing C, Zhu H, Dou X, et al. · ACS Nano · 2023Research Support, Non-U.S. Gov't
- High-Intensity Blue Light (450-460ߙnm) Phototherapy for Pseudomonas aeruginosa-Infected Wounds.
Zoric A, Bagheri M, von Kohout M, et al. · Photobiomodul Photomed Laser Surg · 2024
- The Efficacy of Breast Implant Irrigant Solutions: A Comparative Analysis Using an In Vitro Model.
Ngaage LM, Elegbede A, Brao K, et al. · Plast Reconstr Surg · 2020Comparative Study
- Combined carbon photon and hydrogel therapy mediates the synergistic repair of full-thickness skin wounds.
Yang F, Zhou X, Chen S, et al. · J Int Med Res · 2020
- Injectable antibacterial tissue-adhesive hydrogel based on biocompatible o-phthalaldehyde/amine crosslinking for efficient treatment of infected wounds.
Zou Z, Zhang Z, Ren H, et al. · Biomaterials · 2023Research Support, Non-U.S. Gov't
- Chemiluminescence-Based IgE Dot-Blot Assay in the Diagnosis of Anaphylaxis Caused by Prontosan.
Rodríguez-Pérez R, Del Pozuelo S, Pulido E, et al. · J Investig Allergol Clin Immunol · 2024
- The Impact of Antiseptic-Loaded Bacterial Nanocellulose on Different Biofilms-An Effective Treatment for Chronic Wounds?
Luze H, Bernardelli de Mattos I, Nischwitz SP, et al. · J Clin Med · 2022
- An In Vitro Model of the Efficacy of Breast Implant Irrigant Solutions Against Gram-Negative Infections.
Ha M, Ngaage LM, Smith RD, et al. · Ann Plast Surg · 2022
Other devices of this type
Also filed under product code FRO.
- Vashe Wound Solution (4.0 Oz), (8.5 Oz & (16.0 Oz)Puricore, Inc. · 510(k) 2014
- Acryderm Silver Antimicrobial Foam Wound DressingAcrymed, Inc. · 510(k) 2009
- Silverlon Island Wound DressingArgentum Medical, LLC · 510(k) 2019
- LUOFUCON® Extra Silver Gelling Fiber Dressing Plus (Prescription use),LUOFUCON® Silver Antimicrobial Gelling Fiber Dressing Plus (OTC use)Huizhou Foryou Medical Devices Co., Ltd. · 510(k) 2024
- Silverlon® Wound Contact, Burn Contact DressingArgentum Medical, LLC · 510(k) 2024
- Sorbact Wound Dressing-Ribbon GauzeAbigo Medical AB · 510(k) 2017
- Exsalt SD7 Wound Dressing with Adhesive BackingExciton Technologies, Inc. · 510(k) 2014
- Bioderm Sciences Wound CreamBioderm Sciences, Inc. · 510(k) 2005
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.